Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: Multicenter, phase Ib dose escalation and expansion study

  1. Santin, A.D.
  2. Vergote, I.
  3. González-Martín, A.
  4. Moore, K.
  5. Oaknin, A.
  6. Romero, I.
  7. Diab, S.
  8. Copeland, L.J.
  9. Monk, B.J.
  10. Coleman, R.L.
  11. Herzog, T.J.
  12. Siegel, J.
  13. Kasten, L.
  14. Schlicker, A.
  15. Schulz, A.
  16. Köchert, K.
  17. Walter, A.O.
  18. Childs, B.H.
  19. Elbi, C.
  20. Bulat, I.
Aldizkaria:
International Journal of Gynecological Cancer

ISSN: 1525-1438,  1048-891X

Argitalpen urtea: 2023

Alea: 33

Zenbakia: 4

Orrialdeak: 562-570

Mota: Artikulua

DOI: 10.1136/IJGC-2022-003927 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus